167.11
price up icon0.39%   0.65
 
loading
Schlusskurs vom Vortag:
$166.46
Offen:
$166.47
24-Stunden-Volumen:
1.37M
Relative Volume:
1.37
Marktkapitalisierung:
$18.55B
Einnahmen:
$9.54B
Nettoeinkommen (Verlust:
$841.00M
KGV:
22.46
EPS:
7.44
Netto-Cashflow:
$1.02B
1W Leistung:
-1.79%
1M Leistung:
-2.98%
6M Leistung:
+9.23%
1J Leistung:
+29.71%
1-Tages-Spanne:
Value
$165.88
$167.55
1-Wochen-Bereich:
Value
$163.69
$174.88
52-Wochen-Spanne:
Value
$125.42
$178.87

Quest Diagnostics Inc Stock (DGX) Company Profile

Name
Firmenname
Quest Diagnostics Inc
Name
Telefon
(973) 520-2700
Name
Adresse
500 PLAZA DRIVE, SECAUCUS
Name
Mitarbeiter
0
Name
Twitter
@QuestDX
Name
Nächster Verdiensttermin
2024-10-22
Name
Neueste SEC-Einreichungen
Name
DGX's Discussions on Twitter

Vergleichen Sie DGX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
167.11 18.55B 9.54B 841.00M 1.02B 7.44
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
517.72 195.32B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
211.36 151.06B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
120.75 34.43B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
420.99 34.24B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
185.89 32.78B 15.41B 1.37B 2.11B 7.50

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-04 Herabstufung Citigroup Buy → Neutral
2025-01-06 Hochstufung Leerink Partners Market Perform → Outperform
2024-12-17 Hochstufung Morgan Stanley Equal-Weight → Overweight
2024-12-10 Fortgesetzt Jefferies Buy
2024-10-23 Hochstufung Robert W. Baird Neutral → Outperform
2024-08-28 Fortgesetzt Evercore ISI In-line
2024-07-10 Hochstufung Citigroup Neutral → Buy
2024-02-26 Eingeleitet Leerink Partners Market Perform
2024-02-07 Hochstufung Jefferies Hold → Buy
2024-01-03 Eingeleitet Barclays Equal Weight
2023-12-12 Hochstufung BofA Securities Neutral → Buy
2023-06-29 Eingeleitet Piper Sandler Neutral
2023-05-02 Herabstufung BofA Securities Buy → Neutral
2023-04-03 Hochstufung Citigroup Sell → Neutral
2023-01-23 Eingeleitet Evercore ISI In-line
2022-11-17 Herabstufung Citigroup Neutral → Sell
2022-08-22 Fortgesetzt Morgan Stanley Equal-Weight
2022-04-04 Herabstufung Citigroup Buy → Neutral
2022-02-23 Herabstufung UBS Buy → Neutral
2022-02-02 Herabstufung Jefferies Buy → Hold
2022-01-28 Herabstufung Deutsche Bank Buy → Hold
2021-05-04 Hochstufung UBS Neutral → Buy
2021-03-12 Herabstufung Robert W. Baird Outperform → Neutral
2020-10-21 Hochstufung Argus Hold → Buy
2020-07-29 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2020-07-14 Hochstufung BofA Securities Neutral → Buy
2020-06-09 Hochstufung Wells Fargo Underweight → Equal Weight
2020-06-02 Hochstufung Deutsche Bank Hold → Buy
2020-04-28 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-04-27 Hochstufung Citigroup Neutral → Buy
2020-04-27 Hochstufung Wolfe Research Underperform → Peer Perform
2020-03-27 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-01-08 Eingeleitet Wells Fargo Underweight
2020-01-07 Herabstufung Barclays Overweight → Equal Weight
2019-12-19 Hochstufung BofA/Merrill Underperform → Neutral
2019-07-15 Herabstufung Goldman Neutral → Sell
2019-04-02 Hochstufung Jefferies Hold → Buy
2019-03-18 Fortgesetzt Credit Suisse Neutral
2019-01-31 Herabstufung Argus Buy → Hold
2019-01-17 Eingeleitet UBS Neutral
2019-01-03 Herabstufung BofA/Merrill Neutral → Underperform
2018-12-03 Herabstufung BofA/Merrill Buy → Neutral
2018-11-30 Herabstufung Goldman Buy → Neutral
Alle ansehen

Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten

pulisher
Mar 21, 2025

DGX Stock Set to Benefit From New Google Cloud Partnership - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

What 9 Analyst Ratings Have To Say About Quest Diagnostics - Benzinga

Mar 20, 2025
pulisher
Mar 20, 2025

Earnings Summary: Quest Diagnostics (DGX) reaffirms FY25 guidance - AlphaStreet

Mar 20, 2025
pulisher
Mar 20, 2025

Baird Adjusts Price Target on Quest Diagnostics to $191 From $190, Keeps Outperform Rating - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

Quest Diagnostics' (NYSE:DGX) Dividend Will Be Increased To $0.80 - Yahoo Finance

Mar 20, 2025
pulisher
Mar 19, 2025

Quest Diagnostics SVP Michael Prevoznik sells $789,310 in stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the Spotlight - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

Quest Diagnostics (DGX) Unveils Strategic Plans at Investor Day - GuruFocus.com

Mar 19, 2025
pulisher
Mar 19, 2025

Quest Diagnostics stock falls on Q1 headwinds (DGX:NYSE) - Seeking Alpha

Mar 19, 2025
pulisher
Mar 19, 2025

Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day - Quantisnow

Mar 19, 2025
pulisher
Mar 19, 2025

Quest Diagnostics projects steady growth beyond 2025 - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Quest Diagnostics Lowers Q1 Outlook, Reaffirms 2025 Guidance -March 19, 2025 at 08:42 am EDT - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Quest Diagnostics Reveals Ambitious Growth Strategy: 5 Key Areas Set to Drive Double-Digit Expansion - StockTitan

Mar 19, 2025
pulisher
Mar 18, 2025

Quest Diagnostics (NYSE:DGX) Leverages Google Cloud AI For Enhanced Patient Experience - Simply Wall St

Mar 18, 2025
pulisher
Mar 18, 2025

Quest Diagnostics Revolutionizes Lab Testing With Google Cloud AI Partnership - StockTitan

Mar 18, 2025
pulisher
Mar 17, 2025

Baird Adjusts Price Target on Quest Diagnostics to $190 From $189, Maintains Outperform Rating - Marketscreener.com

Mar 17, 2025
pulisher
Mar 16, 2025

Quest Diagnostics Reports Third Quarter 2023 Financial Results; Updates Guidance for Full Year 2023 - GuruFocus.com

Mar 16, 2025
pulisher
Mar 14, 2025

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX) - Barchart

Mar 14, 2025
pulisher
Mar 14, 2025

Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Mar 14, 2025
pulisher
Mar 11, 2025

SBI Securities Co. Ltd. Takes Position in Quest Diagnostics Incorporated (NYSE:DGX) - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Blood Cancer Diagnostics Market Analysis Report 2025-2030, with Quest Diagnostics, Illumina, InVivoScribe, Asuragen, Danaher, Sequenta, SkylineDx, Bio-Rad Laboratories, Alercell & Sophia Genetics - Yahoo Finance

Mar 10, 2025
pulisher
Mar 09, 2025

Catherine T. Doherty Sells 5,370 Shares of Quest Diagnostics Incorporated (NYSE:DGX) Stock - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Quest Diagnostics EVP Catherine Doherty sells $935,078 in stock By Investing.com - Investing.com Australia

Mar 08, 2025
pulisher
Mar 08, 2025

Mutual of America Capital Management LLC Decreases Stake in Quest Diagnostics Incorporated (NYSE:DGX) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Quest Diagnostics EVP Catherine Doherty sells $935,078 in stock - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Quest Diagnostics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

Citigroup Downgrades Quest Diagnostics (NYSE:DGX) to Neutral - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Quest Diagnostics EVP sells $125,865 in stock - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Quest Diagnostics EVP sells $125,865 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

SVP, Clinical Solutions Kuppusamy Karthik covered exercise/tax liability with 2,871 shares and was granted 4,434 shares, increasing direct ownership by 14% to 13,119 units (SEC Form 4) - Quantisnow

Mar 05, 2025
pulisher
Mar 05, 2025

Labcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns — Retail Sentiment Mixed - MSN

Mar 05, 2025
pulisher
Mar 04, 2025

Quest Diagnostics Incorporated : Your health comes first -March 04, 2025 at 10:54 pm EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

The Analyst Verdict: Quest Diagnostics In The Eyes Of 11 Experts - Benzinga

Mar 04, 2025
pulisher
Mar 04, 2025

This Teleflex Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday - Benzinga

Mar 04, 2025
pulisher
Mar 04, 2025

Citigroup Downgrades Quest Diagnostics to Neutral From Buy, Price Target is $185 -March 04, 2025 at 05:37 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 03, 2025

Quest Diagnostics Stock Hits All-Time High at $176.53 By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

Quest Diagnostics Stock Jumps 38% in a Year: What's Behind the Surge? - Nasdaq

Mar 03, 2025
pulisher
Mar 01, 2025

Pine Valley Investments Ltd Liability Co Decreases Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

SVB Wealth LLC Acquires Shares of 68,575 Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

National Pension Service Sells 9,262 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Versor Investments LP Has $664,000 Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Quest Diagnostics EVP Catherine Doherty sells $142,230 in stock By Investing.com - Investing.com Canada

Mar 01, 2025
pulisher
Mar 01, 2025

Quest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by Bank of New York Mellon Corp - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Global Retirement Partners LLC Acquires 173 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Quest Diagnostics (NYSE:DGX) Reaches New 52-Week HighStill a Buy? - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Quest Diagnostics SVP sells $91,138 in stock By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

Quest Diagnostics EVP Catherine Doherty sells $142,230 in stock - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

Quest Diagnostics SVP sells $91,138 in stock - Investing.com India

Feb 28, 2025
pulisher
Feb 28, 2025

IFP Advisors Inc Has $2.35 Million Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

QRG Capital Management Inc. Purchases 2,012 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Atria Wealth Solutions Inc. Purchases 425 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - Defense World

Feb 28, 2025

Finanzdaten der Quest Diagnostics Inc-Aktie (DGX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research LH
$234.21
price down icon 0.67%
$151.15
price up icon 1.02%
diagnostics_research WAT
$365.46
price up icon 0.62%
diagnostics_research MTD
$1,199.21
price down icon 0.10%
diagnostics_research IQV
$185.89
price up icon 0.88%
Kapitalisierung:     |  Volumen (24h):